INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

SILVERCREST ASSET MANAGEMENT GROUP LLC's Holding History (CIK: 0001232395)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 118,265 Value ($000) $9,877 Avg Close — Range —
Q3 2024
Shares 118,848 Value ($000) $8,696 Avg Close — Range —
Q2 2024
Shares 119,570 Value ($000) $8,189 Avg Close — Range —
Q1 2024
Shares 42,276 Value ($000) $2,925 Avg Close — Range —
Q4 2023
Shares 55,783 Value ($000) $3,995 Avg Close — Range —
Q3 2023
Shares 78,374 Value ($000) $4,083 Avg Close — Range —
Q2 2023
Shares 78,444 Value ($000) $4,967 Avg Close — Range —
Q1 2023
Shares 66,718 Value ($000) $3,613 Avg Close — Range —
Q4 2022
Shares 98,474 Value ($000) $5,211 Avg Close — Range —
Q3 2022
Shares 99,930 Value ($000) $4,650 Avg Close — Range —
Q2 2022
Shares 102,414 Value ($000) $5,846 Avg Close — Range —
Q1 2022
Shares 107,838 Value ($000) $6,599 Avg Close — Range —
Q4 2021
Shares 106,559 Value ($000) $5,577 Avg Close — Range —
Q3 2021
Shares 167,311 Value ($000) $6,237 Avg Close — Range —
Q2 2021
Shares 169,994 Value ($000) $6,939 Avg Close — Range —
Q1 2021
Shares 170,333 Value ($000) $5,779 Avg Close — Range —
Q4 2020
Shares 191,850 Value ($000) $6,101 Avg Close — Range —